Acanthosis Nigricans as an early clinical proxy marker of increased risk of type II diabetes.
Diabetes affects 6% of the national population, yet approximately 50% of persons with diabetes remain undiagnosed and receive no treatment. In specific populations, Acanthosis Nigricans (AN) may serve as an early clinical proxy marker of increased risk of type II diabetes. The results of this pilot project to screen selected school age students in New Mexico for AN indicate that a large number of these students may be at increased risk for developing type II diabetes as young adults. The future burden of diabetes on individuals, families, communities, and health care systems may be greater than previously recognized.
Bent
K N
KN
Health Facilities Division of the Colorado Department of Public Health and Environment, University of Colorado School of Nursing, USA.
Shuster
G F
GF
Hurley
J S
JS
Frye
D
D
Loflin
P
P
Brubaker
C
C
D000052:Acanthosis Nigricans / Q000150:complications*; D000328:Adult; D015415:Biomarkers; D002648:Child; D003924:Diabetes Mellitus, Type 2 / Q000208:ethnology / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D009516:New Mexico; D010865:Pilot Projects; D012307:Risk Factors; D012572:School Health Services; D012573:School Nursing / Q000193:education
D015415:Biomarkers